Brief Report J. Impact of PARP-1 and DNA-PK expres- sion on survival in patients with glioblas- toma multiforme. Radiother Oncol 2011;101:127-31. 14. Cookson MR, Ince PG, Usher PA, Shaw PJ. Poly(ADP-ribose) polymerase is found in both the nucleus and cytoplasm of human CNS neurons. Brain Res 1999;834:182-5. 15. Wharton SB, McNelis U, Bell HS, Whittle IR. Expression of poly(ADP-ribose) poly- merase and of poly(ADP-ribosyl)ation in glioblastoma and in a glioma multicellu- lar tumour spheroid model. Neuropathol Appl Neurobiol 2000;26:528-35. 16. Ha HC, Snyder SH. Poly (ADP-ribose) poly- merase is a mediator of necrotic cell death by ATP depletion. Proc Natl Acad Sci USA 1999;96:13978-82. 17. Calogero AE, Soma PF, Giuffrida MC, Giuffrida D, La Vignera S, Romano C, et al. PARP1 and CASP3 gene expression in a patient with multiple head and neck squa- mous cell carcinoma and Parkinson dis- ease. Hum Cell. 2011 [Epub ahead of print]. 18. Eustermann S, Videler H, Yang JC, Cole PT, Gruszka D, Veprintsev D, Neuhaus D. The DNA-binding domain of human PARP- 1 interacts with DNA single-strand breaks as a monomer through its second zinc fin- ger. J Mol Biol 2011; 407:149-70. 19. Kannan S, Fang W, Song G, Mullighan CG, Hammitt R, McMurray J. et al. Notch/HES1-mediated PARP1 activation: a cell-type specific mechanism for tumor suppression. Blood 2011;117:2891-900. 20. Schreiber V, Dantzer F, Ame JC, de Murcia G. Poly(ADP-ribose): novel functions for an old molecule. Nat Rev Mol Cell Biol 2006;7:517-28. 21. Paquet-Durand F, Silva J, Talukdar T, Jonhnson LE, Azadi S, van Veen T, et al. Excessive activation of poly (ADP-ribose) ploymerase contributes to inherited pho- toreceptor degeneration in the retinal degeneration 1 mouse. The Journal of Neuroscience 2007;27:10311-9. 22. Sahaboglu A, Tanimoto N, Kaur J, Sancho- Pelluz J, Huber G, Fahl E, et al. PARP1 gene knock-out increases resistance to retinal degeneration without affecting retinal function. PLoS One 2010;5:e15495. 23. Tentori L, Leonetti C, Scarsella M, D'Amati G, Vergati M, Portarena I, et al. Systemic administration of GPI 15427, a novel poly(ADP-ribose) polymerase-1 inhibitor, increases the antitumor activity of temo- zolomide against intracranial melanoma, glioma, lymphoma. Clin Cancer Res 2003; 9:5370-9. 24. Russo AL, Kwon HC, Burgan WE, Carter D, Beam K, Weizheng X, et al. In vitro and in vivo radiosensitization of glioblastoma cells by the poly (ADP-ribose) polymerase inhibitor E7016. Clin Cancer Res 2009;15: 607-12. 25. McEllin B, Camacho CV, Mukherjee B, Hahm B, Tomimatsu N, Bachoo RM et al. PTEN loss compromises homologous recombination repair in astrocytes: impli- cations for glioblastoma therapy with temozolomide or poly(ADP-ribose) poly- merase inhibitors. Cancer Res 2010;70: 5457-64. 26. Ahmad M, Torky A, Glahn F, Scheubel RJ, Foth H. PARP-1 expression and activity in primary human lung cells. Arch Toxicol 2011;85:669-79. [page 48] [European Journal of Histochemistry 2012; 56:e9]